Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation

por Yamane, Hiromichi, Ochi, Nobuaki, Yasugi, Masayuki, Tabayashi, Takayuki, Yamagishi, Tomoko, Monobe, Yasumasa, Hisamoto, Akiko, Kiura, Katsuyuki, Takigawa, Nagio
Publicado 2013

Obstructive jaundice at the initial presentation in small-cell lung cancer

por Ochi, Nobuaki, Takigawa, Nagio, Yasugi, Masayuki, Ishida, Etsuji, Kawamoto, Hirofumi, Taniguchi, Akihiko, Harada, Daijiro, Hayashi, Eiko, Toda, Hiroko, Yanai, Hiroyuki, Tanimoto, Mitsune, Kiura, Katsuyuki
Publicado 2010

A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rea...

por Harada, Daijiro, Kozuki, Toshiyuki, Nogami, Naoyuki, Bessho, Akihiro, Hosokawa, Shinobu, Fukamatsu, Nobuaki, Hotta, Katsuyuki, Ohashi, Kadoaki, Kubo, Toshio, Yoshioka, Hiroshige, Yokoyama, Toshihide, Sone, Naoyuki, Kuyama, Shoichi, Kudo, Kenichiro, Yasugi, Masayuki, Takigawa, Nagio, Oze, Isao, Kiura, Katsuyuki
Publicado 2019

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI s...

por Tanaka, Hisashi, Tanzawa, Shigeru, Misumi, Toshihiro, Makiguchi, Tomonori, Inaba, Megumi, Honda, Takeshi, Nakamura, Junya, Inoue, Koji, Kishikawa, Takayuki, Nakashima, Masanao, Fujiwara, Keiichi, Kohyama, Tadashi, Ishida, Hiroo, Kuyama, Shoichi, Miyazawa, Naoki, Nakamura, Tomomi, Miyawaki, Hiroshi, Oda, Naohiro, Ishikawa, Nobuhisa, Morinaga, Ryotaro, Kusaka, Kei, Fujimoto, Nobukazu, Fukuda, Yasushi, Yasugi, Masayuki, Tsuda, Takeshi, Ushijima, Sunao, Shibata, Kazuhiko, Shibayama, Takuo, Bessho, Akihiro, Kaira, Kyoichi, Shiraishi, Kenshiro, Matsutani, Noriyuki, Seki, Nobuhiko
Publicado 2022